KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)
CUSIP: 483497103
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 50,580,036
- Total 13F shares
- 23,950,478
- Share change
- -1,023,340
- Total reported value
- $353,046,504
- Put/Call ratio
- 0%
- Price per share
- $14.74
- Number of holders
- 84
- Value change
- -$11,733,222
- Number of buys
- 38
- Number of sells
- 46
Quarterly Holders Quick Answers
What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 483497103:
Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3.8%
|
1,930,322
|
$25,538,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.6%
|
1,811,505
|
$23,966,000 | — | 31 Dec 2021 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.5%
|
1,746,300
|
$23,104,000 | — | 31 Dec 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
3%
|
1,533,559
|
$20,289,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3%
|
1,504,620
|
$19,906,000 | — | 31 Dec 2021 | |
| Deep Track Capital, LP |
13F
|
Company |
3%
|
1,500,000
|
$19,845,000 | — | 31 Dec 2021 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
2.6%
|
1,305,087
|
$17,266,000 | — | 31 Dec 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.5%
|
1,252,142
|
$16,565,000 | — | 31 Dec 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.3%
|
1,175,131
|
$15,547,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
1,138,484
|
$15,062,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,051,976
|
$13,918,000 | — | 31 Dec 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.7%
|
884,339
|
$11,700,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
1.6%
|
787,220
|
$10,415,000 | — | 31 Dec 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.93%
|
470,000
|
$6,218,000 | — | 31 Dec 2021 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.81%
|
411,937
|
$5,450,000 | — | 31 Dec 2021 | |
| Prosight Management, LP |
13F
|
Company |
0.81%
|
409,620
|
$5,419,000 | — | 31 Dec 2021 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.76%
|
383,233
|
$5,066,000 | — | 31 Dec 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.75%
|
379,233
|
$5,017,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.75%
|
377,970
|
$5,000,000 | — | 31 Dec 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.63%
|
316,200
|
$4,183,000 | — | 31 Dec 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.62%
|
312,553
|
$4,135,000 | — | 31 Dec 2021 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.59%
|
300,000
|
$3,969,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.5%
|
254,909
|
$3,372,000 | — | 31 Dec 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.38%
|
190,663
|
$2,522,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.33%
|
168,331
|
$2,227,000 | — | 31 Dec 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
138,821
|
$1,837,000 | — | 31 Dec 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.27%
|
138,738
|
$1,836,000 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.23%
|
115,122
|
$1,523,000 | — | 31 Dec 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.22%
|
111,834
|
$1,480,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.2%
|
99,431
|
$1,315,000 | — | 31 Dec 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.19%
|
97,592
|
$1,291,000 | — | 31 Dec 2021 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
0.18%
|
92,000
|
$1,217,000 | — | 31 Dec 2021 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.16%
|
78,720
|
$1,041,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.13%
|
67,351
|
$891,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
65,732
|
$870,000 | — | 31 Dec 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.13%
|
64,186
|
$849,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
63,084
|
$835,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
63,100
|
$796,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
57,415
|
$760,000 | — | 31 Dec 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.11%
|
54,127
|
$716,000 | — | 31 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
53,563
|
$708,000 | — | 31 Dec 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.08%
|
41,087
|
$544,000 | — | 31 Dec 2021 | |
| Birchview Capital, LP |
13F
|
Company |
0.08%
|
40,000
|
$529,000 | — | 31 Dec 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.07%
|
36,576
|
$484,000 | — | 31 Dec 2021 | |
| CSS LLC/IL |
13F
|
Company |
0.07%
|
34,999
|
$463,000 | — | 31 Dec 2021 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.07%
|
33,696
|
$446,000 | — | 31 Dec 2021 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.06%
|
31,594
|
$418,000 | — | 31 Dec 2021 | |
| APOGEM CAPITAL LLC |
13F
|
Company |
0.06%
|
30,763
|
$407,000 | — | 31 Dec 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
30,423
|
$402,000 | — | 31 Dec 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
28,986
|
$383,000 | — | 31 Dec 2021 |
Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q1 2022
As of 31 Mar 2022,
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by
84 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,950,478 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, Deep Track Capital, LP, Frazier Life Sciences Management, L.P., BlackRock Inc., Vivo Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, and STATE STREET CORP.
This page lists
84
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
93
Q1 2022 holders
84
Holder diff
-9
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.